Cardiac Surgery Clinical Trials
As a patient at Cedars-Sinai, you will have access to the latest clinical trials and research for cardiac surgery. Backed by a respected team of specialists and researchers, our clinical trials aim to further the advancement of diagnosing and treating your condition.
Questions? See the Clinical Trials FAQs.
Condition:
Mitral valve regurgitation
Key Inclusion Criteria:
- Adult patients ≥65 years old with moderately severe or severe primary
degenerative mitral valve regurgitation (MR) - Clinical indication for mitral valve (MV) intervention and anatomic candidate for both MV transcatheter edge-to-edge and surgical repair
- Patients across the surgical risk spectrum (low, intermediate, and high risk)
Summary:
The purpose of this study is to compare the risks and benefits of two procedures used to help patients with mitral valve regurgitation (MR). The study will compare transcatheter edge-to-edge repair (TEER- a catheter procedure for repairing the mitral valve that does not require surgery to open up the heart) and mitral valve repair surgery, an open-heart surgical procedure.